November 6, 2008
Glenn Brown's visionary prediction becoming a reality through LCPs

LCI Founder, Dr. Glenn H. Brown, predicted many years ago that the next big breakthrough in LC technologies would come from biological applications. Today, we are seeing more and more biological applications of liquid crystals. One recent highlight is the research and development of liquid crystal pharmaceuticals (LCPs) (collaboratively developed by researchers at Kent State University, University of Akron, Summa Health System, NEOUCOM and IC-MedTech) which may soon be approved for the treatment of diseases ranging from cancer and viral infections to obesity and Alzheimer's.

Please go to the following links to find out more about this new biotechnology related to liquid crystals and its possible opportunities for future research and development in Ohio.

Learn about Apatone® and Tolecine™

Kent State Magazine article: "Those Amazing Liquid Crystals: New liquid crystal technology offers hope for treatment of cancer, other diseases [PDF]

http://cms.kent.edu/media/NewsReleases/LCP.cfm

http://www.ic-medtech.com/

http://www.medsci.org/v05p0062.htm

http://www.summahealth.org/common/templates/article.asp?ID=12801

http://dept.kent.edu/chemistry/General/Tsai%20Research.pdf

http://www.bio-medicine.org/biology-news-1/Researchers-develop-liquid-crystal-pharmaceuticals-to-fight-cancer-and-other-diseases-291-1/